Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Filings indexed 501 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
반기또는분기매출액미달사실발생
Regulatory Filings Classification · 85% confidence The document is a brief regulatory disclosure in Korean announcing that quarterly sales fell below a specified threshold. It does not contain a full interim report or detailed financial analysis, but simply notifies investors of a sales shortfall with minimal financial data. This matches a general regulatory announcement category, i.e., Regulatory Filings (RNS), rather than a full interim report (IR) or a report publication notice (RPA).
2026-05-15 Korean
기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)
Regulatory Filings Classification · 80% confidence The document is a Korean regulatory notice (“기타시장안내”) regarding additional listing-eligibility review procedures for 올리패스, referencing KOSDAQ rules and prior delisting decision. It provides a compliance update rather than financial results, a board change, or shareholder vote. This fits a general regulatory announcement (RNS) rather than a delisting announcement (DLST) or other specific categories.
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is clearly a "분기보고서" (Korean Quarterly Report) covering the 1st quarter of fiscal year 2026 (Jan 1–Mar 31, 2026). It contains extensive financial statements, detailed company overview, subsidiary schedules, share capital data, and other substantive financial disclosures characteristic of a full interim/quarterly filing, not merely an announcement. Therefore, it fits the "Interim / Quarterly Report" category. Q1 2026
2026-05-15 Korean
기타경영사항(자율공시)
Legal Proceedings Report Classification · 85% confidence The document is a voluntary disclosure (자율공시) detailing a court decision on property preservation and comprehensive injunction applications by the Suwon Bankruptcy Court. It provides updates on legal proceedings rather than financial results, management changes, or report publications. This aligns with the “Legal Proceedings Report” category.
2026-05-12 Korean
주요사항보고서(회생절차개시신청)
Regulatory Filings Classification · 100% confidence The document is titled '주요사항보고서(회생절차 개시신청)' which translates to 'Major Event Report (Application for Commencement of Rehabilitation Proceedings)'. It is addressed to the Financial Services Commission and Korea Exchange, dated May 7, 2026. The content describes the company's board decision to apply for rehabilitation proceedings at the Suwon Rehabilitation Court, including preservation of company assets and comprehensive injunctions. It mentions that the court will review the application and that the company will disclose further developments. The document is a regulatory announcement about a significant legal/financial event (rehabilitation procedure application) rather than a full report or financial statement. It is short (951 characters) and serves as a notification to regulators and investors about a material event. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-05-07 Korean
기타시장안내 (회생절차 개시신청 관련 시장안내)
Delisting Announcement Classification · 95% confidence The document is a market notice regarding the company's filing for rehabilitation proceedings and the related suspension of delisting procedures. It references a prior delisting decision and a court injunction suspending the delisting process. The content is an official announcement about the company's market status and regulatory events, specifically about delisting and legal proceedings affecting it. The document is short (464 characters) and serves as an announcement rather than a detailed report. Given the focus on delisting and the nature of the announcement, the appropriate classification is Delisting Announcement (DLST).
2026-05-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.